查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
品牌學名藥市場 - 按藥物類別（抗高血壓、荷爾蒙、抗代謝物）、應用（腫瘤、心血管疾病）、給藥途徑（口服、外用）、配銷通路（醫院藥房）、全球預測，2023 - 2032 年
市場調查報告書
商品編碼
1368713

品牌學名藥市場 - 按藥物類別（抗高血壓、荷爾蒙、抗代謝物）、應用（腫瘤、心血管疾病）、給藥途徑（口服、外用）、配銷通路（醫院藥房）、全球預測，2023 - 2032 年

Branded Generics Market - By Drug Class (Anti-hypertensive, Hormones, Antimetabolites), Application (Oncology, Cardiovascular Diseases), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacy), Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

全球品牌學名藥市場規模將在 2023 年至 2032 年間呈現顯著成長。旨在推廣學名藥的政府措施可以對市場產生刺激作用。 2023年9月，瑞士政府批准了《健康保險條例》、《醫療保健服務條例》和《藥品條例》的修改，計劃於2024年1月1日實施。這些修改旨在提高學名藥的成本— —與品牌同行相比，這種方法有效，同時也提高了患者選擇更昂貴的選擇的共同付款。這項策略性舉措旨在每年節省 2.5 億瑞士法郎，相當於 2.75 億美元。

透過鼓勵使用更實惠的學名藥替代品，政府政策創造了一個競爭環境，促使製藥公司在生產品牌學名藥方面進行創新。這種競爭可以帶來更廣泛的高品質、具有成本效益的品牌學名藥，透過增加藥品市場的選擇和潛在的更低價格使消費者受益。

整個品牌學名藥市場根據藥物類別、應用、給藥途徑、配銷通路和地區進行分類。

到 2032 年，心血管疾病領域可能會主導品牌學名藥行業的應用領域。患者和醫療保健專業人員通常更喜歡關鍵藥物的值得信賴的品牌，以確保可靠性和品質。此外，品牌學名藥可以提供滿足患者偏好和需求的特定配方或給藥方法。人們對心血管健康的認知不斷增強以及對有效、完善的治療方法的關注進一步推動了這種需求。

到 2032 年，外用品牌學名藥市場將呈現健康的成長速度。由於其有效性、可負擔性和熟悉度，外用品牌學名藥的銷售量正在上升。消費者信任知名品牌的皮膚和保健產品，使其成為首選。熱門品牌學名藥通常以較低的成本提供與品牌學名藥相同的品質和性能，吸引了注重成本的消費者。人們對皮膚健康的認知不斷增強，以及這些值得信賴的替代品的出現，促使它們在市場上越來越受歡迎。

由於幾個關鍵因素，歐洲品牌學名藥產業正在經歷強勁成長。歐洲消費者優先考慮品質並信任藥品的知名品牌，即使是非專利藥品。此外，該地區的醫療保健系統鼓勵使用具有成本效益的學名藥，這對患者和政府預算都有好處。監管框架還支持品牌學名藥的成長，為製藥公司提供這些值得信賴的替代品創造有利的環境。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：品牌學名藥產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性病盛行率上升
      • 過期專利數量不斷增加
      • 政府加大力度推廣學名藥
    • 產業陷阱與挑戰
      • 來自標準學名藥和品牌藥的競爭
      • 監管障礙
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：品牌學名藥市場：按藥物類別，2018 - 2032 年

  • 主要動向：依藥物類別
  • 抗高血壓
  • 荷爾蒙
  • 抗代謝藥
  • 抗憂鬱藥
  • 烷基化劑
  • 降血脂藥
  • 抗癲癇藥
  • 抗精神病藥
  • 其他藥物類別

第 6 章：品牌學名藥市場：按應用，2018 年 - 2032 年

  • 主要動向：按應用
  • 腫瘤學
  • 心血管疾病
  • 神經系統疾病
  • 胃腸道疾病
  • 皮膚科疾病
  • 急性和慢性疼痛
  • 其他應用

第 7 章：品牌學名藥市場：依管理途徑分類，2018 年 - 2032 年

  • 主要動向：按給藥途徑
  • 口服
  • 專題
  • 注射用
  • 其他給藥途徑

第 8 章：品牌學名藥市場：按配銷通路分類，2018 年 - 2032 年

  • 主要動向：按配銷通路
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第 9 章：品牌學名藥市場：按地區分類，2018 年 - 2032 年

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Teva Pharmaceutical Industries Ltd.
  • Lupin
  • Sanofi
  • Sun Pharmaceutical Industries, Ltd.
  • Dr. Reddy's Laboratories Ltd
  • Endo International plc
  • Pfizer, Inc.
  • Viatris, Inc.
  • Abbott Laboratories
  • Sandoz
Product Code: 6565

Global Branded Generics Market size will exhibit an appreciable growth rate between 2023 and 2032. Government initiatives aimed at promoting generic products can have a stimulating effect on the market. In September 2023, the Swiss government approved changes to the Ordinance on Health Insurance, the Ordinance on Health Care Services, and the Ordinance on Medicinal Products, scheduled to be implemented on January 1, 2024. These revisions aim to make generic drugs more cost-effective compared to their brand-name counterparts while also raising patients' co-payments for selecting pricier options. This strategic move is designed to achieve annual savings of CHF 250 million, equivalent to $275 million.

By encouraging the use of more affordable generic alternatives, government policies create a competitive environment, prompting pharmaceutical companies to innovate in producing branded generic products. This competition can lead to a wider range of high-quality, cost-effective branded generics, benefiting consumers with increased choices and potentially lower prices in the pharmaceutical market.

The overall branded generics market is categorized based on drug class, application, route of administration, distribution channel, and region.

The cardiovascular disease segment could dominate the application landscape of the branded generics industry by 2032. Patients and healthcare professionals often prefer trusted brand names for critical medications, ensuring reliability and quality. Additionally, branded generics may offer specific formulations or delivery methods that cater to patient preferences and needs. This demand is further propelled by a growing awareness of cardiovascular health and a focus on effective, well-established treatments.

Topical branded generics market will demonstrate a healthy growth rate through 2032. Sales of topical branded generics are on the rise due to their effectiveness, affordability, and familiarity. Consumers trust well-known brand names for skin and healthcare products, making them a preferred choice. Topical branded generics often offer the same quality and performance as their brand-name counterparts at a lower cost, appealing to cost-conscious consumers. The increasing awareness of skin health and the availability of these trusted alternatives contribute to their growing popularity in the market.

Europe branded generics industry is experiencing robust growth due to several key factors. European consumers prioritize quality and trust established brand names for pharmaceuticals, even in generic forms. Additionally, healthcare systems in the region encourage the use of cost-effective generics, benefiting both patients and government budgets. Regulatory frameworks also support the growth of branded generics, creating a favorable environment for pharmaceutical companies to offer these trusted alternatives.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Branded generics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug class trends
    • 2.1.4 Application trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Distribution channel trends

Chapter 3 Branded Generics Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence rate of chronic diseases
      • 3.2.1.2 Rising number of expired patents
      • 3.2.1.3 Increasing government initiatives to promote generic products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Competition from standard generics and brand-name drugs
      • 3.2.2.2 Regulatory barriers
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By application
    • 3.3.3 By route of administration
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Branded Generics Market, By Drug Class, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 Anti-hypertensive
  • 5.3 Hormones
  • 5.4 Antimetabolites
  • 5.5 Anti-depressants
  • 5.6 Alkylating agents
  • 5.7 Lipid lowering drugs
  • 5.8 Anti-epileptics
  • 5.9 Anti-psychotics
  • 5.10 Other drug classes

Chapter 6 Branded Generics Market, By Application, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Oncology
  • 6.3 Cardiovascular diseases
  • 6.4 Neurological diseases
  • 6.5 Gastrointestinal diseases
  • 6.6 Dermatological diseases
  • 6.7 Acute & chronic pain
  • 6.8 Other applications

Chapter 7 Branded Generics Market, By Route of Administration, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Oral
  • 7.3 Topical
  • 7.4 Parenteral
  • 7.5 Other routes of administration

Chapter 8 Branded Generics Market, By Distribution Channel, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacy
  • 8.3 Retail pharmacy
  • 8.4 Online pharmacy

Chapter 9 Branded Generics Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Teva Pharmaceutical Industries Ltd.
  • 10.2 Lupin
  • 10.3 Sanofi
  • 10.4 Sun Pharmaceutical Industries, Ltd.
  • 10.5 Dr. Reddy's Laboratories Ltd
  • 10.6 Endo International plc
  • 10.7 Pfizer, Inc.
  • 10.8 Viatris, Inc.
  • 10.9 Abbott Laboratories
  • 10.10 Sandoz

Data Tables

  • TABLE 1 Market revenue, by drug class (2022)
  • TABLE 2 Market revenue, by route of administration (2022)
  • TABLE 3 Market share, by application (2022)
  • TABLE 4 Market share, by distribution channel (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global branded generics market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global branded generics market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 9 Global branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 10 Global branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 11 Global branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 12 Global branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 13 Global branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 14 Global branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 15 Global branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Anti-hypertensive market size, 2018 - 2022 (USD Million)
  • TABLE 18 Anti-hypertensive market size, 2023 - 2032 (USD Million)
  • TABLE 19 Hormones market size, 2018 - 2022 (USD Million)
  • TABLE 20 Hormones market size, 2023 - 2032 (USD Million)
  • TABLE 21 Antimetabolites market size, 2018 - 2022 (USD Million)
  • TABLE 22 Antimetabolites market size, 2023 - 2032 (USD Million)
  • TABLE 23 Anti-depressants market size, 2018 - 2022 (USD Million)
  • TABLE 24 Anti-depressants market size, 2023 - 2032 (USD Million)
  • TABLE 25 Alkylating agents market size, 2018 - 2022 (USD Million)
  • TABLE 26 Alkylating agents market size, 2023 - 2032 (USD Million)
  • TABLE 27 Lipid lowering drugs market size, 2018 - 2022 (USD Million)
  • TABLE 28 Lipid lowering drugs market size, 2023 - 2032 (USD Million)
  • TABLE 29 Anti-epileptics market size, 2018 - 2022 (USD Million)
  • TABLE 30 Anti-epileptics market size, 2023 - 2032 (USD Million)
  • TABLE 31 Anti-psychotics market size, 2018 - 2022 (USD Million)
  • TABLE 32 Anti-psychotics market size, 2023 - 2032 (USD Million)
  • TABLE 33 Other drug classes market size, 2018 - 2022 (USD Million)
  • TABLE 34 Other drug classes market size, 2023 - 2032 (USD Million)
  • TABLE 35 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 36 Oncology market size, 2023 - 2032 (USD Million)
  • TABLE 37 Cardiovascular diseases market size, 2018 - 2022 (USD Million)
  • TABLE 38 Cardiovascular diseases market size, 2023 - 2032 (USD Million)
  • TABLE 39 Neurological diseases market size, 2018 - 2022 (USD Million)
  • TABLE 40 Neurological diseases market size, 2023 - 2032 (USD Million)
  • TABLE 41 Gastrointestinal diseases market size, 2018 - 2022 (USD Million)
  • TABLE 42 Gastrointestinal diseases market size, 2023 - 2032 (USD Million)
  • TABLE 43 Dermatological diseases market size, 2018 - 2022 (USD Million)
  • TABLE 44 Dermatological diseases market size, 2023 - 2032 (USD Million)
  • TABLE 45 Acute & chronic pain market size, 2018 - 2022 (USD Million)
  • TABLE 46 Acute & chronic pain market size, 2023 - 2032 (USD Million)
  • TABLE 47 Other applications market size, 2018 - 2022 (USD Million)
  • TABLE 48 Other applications market size, 2023 - 2032 (USD Million)
  • TABLE 49 Oral market size, 2018 - 2022 (USD Million)
  • TABLE 50 Oral market size, 2023 - 2032 (USD Million)
  • TABLE 51 Topical market size, 2018 - 2022 (USD Million)
  • TABLE 52 Topical market size, 2023 - 2032 (USD Million)
  • TABLE 53 Parenteral market size, 2018 - 2022 (USD Million)
  • TABLE 54 Parenteral market size, 2023 - 2032 (USD Million)
  • TABLE 55 Other routes of administration market size, 2018 - 2022 (USD Million)
  • TABLE 56 Other routes of administration market size, 2023 - 2032 (USD Million)
  • TABLE 57 Hospital pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 58 Hospital pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 59 Retail pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 60 Retail pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 61 Online pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 62 Online pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 63 North America branded generics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 64 North America branded generics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 65 North America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 66 North America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 67 North America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 68 North America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 69 North America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 70 North America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 71 North America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 72 North America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 73 U.S. branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 74 U.S. branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 75 U.S. branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 76 U.S. branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 77 U.S. branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 78 U.S. branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 79 U.S. branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 80 U.S. branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 81 Canada branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 82 Canada branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 83 Canada branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 84 Canada branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 85 Canada branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 86 Canada branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 87 Canada branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 88 Canada branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 89 Europe branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 90 Europe branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 91 Europe branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 92 Europe branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 93 Europe branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 94 Europe branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 95 Europe branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 96 Europe branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 97 Europe branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 98 Europe branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 99 Germany branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 100 Germany branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 101 Germany branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 102 Germany branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 103 Germany branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 104 Germany branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 105 Germany branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 106 Germany branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 107 UK branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 108 UK branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 109 UK branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 110 UK branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 111 UK branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 112 UK branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 113 UK branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 114 UK branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 115 France branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 116 France branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 117 France branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 118 France branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 119 France branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 120 France branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 121 France branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 122 France branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 123 Spain branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 124 Spain branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 125 Spain branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 126 Spain branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 127 Spain branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 128 Spain branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 129 Spain branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 130 Spain branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 131 Italy branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 132 Italy branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 133 Italy branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 134 Italy branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 135 Italy branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 136 Italy branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 137 Italy branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 138 Italy branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Europe branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Europe branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 141 Rest of Europe branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 142 Rest of Europe branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 143 Rest of Europe branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 144 Rest of Europe branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 145 Rest of Europe branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 146 Rest of Europe branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 147 Asia Pacific branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 148 Asia Pacific branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 149 Asia Pacific branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 150 Asia Pacific branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 151 Asia Pacific branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 152 Asia Pacific branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 153 Asia Pacific branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 154 Asia Pacific branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 155 Asia Pacific branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 156 Asia Pacific branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 157 Japan branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 158 Japan branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 159 Japan branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 160 Japan branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 161 Japan branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 162 Japan branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 163 Japan branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 164 Japan branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 165 China branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 166 China branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 167 China branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 168 China branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 169 China branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 170 China branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 171 China branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 172 China branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 173 India branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 174 India branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 175 India branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 176 India branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 177 India branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 178 India branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 179 India branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 180 India branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 181 Australia branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 182 Australia branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 183 Australia branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 184 Australia branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 185 Australia branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 186 Australia branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 187 Australia branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 188 Australia branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 189 Rest of Asia Pacific branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 190 Rest of Asia Pacific branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Asia Pacific branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Asia Pacific branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 193 Rest of Asia Pacific branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 194 Rest of Asia Pacific branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 195 Rest of Asia Pacific branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 196 Rest of Asia Pacific branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 197 Latin America branded generics Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 198 Latin America branded generics Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 199 Latin America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 200 Latin America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 201 Latin America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 202 Latin America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 203 Latin America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 204 Latin America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 205 Latin America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 206 Latin America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 207 Brazil branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 208 Brazil branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 209 Brazil branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 210 Brazil branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 211 Brazil branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 212 Brazil branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 213 Brazil branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 214 Brazil branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 215 Mexico branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 216 Mexico branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 217 Mexico branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 218 Mexico branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 219 Mexico branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 220 Mexico branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 221 Mexico branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 222 Mexico branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 223 Rest of Latin America branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 224 Rest of Latin America branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 225 Rest of Latin America branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 226 Rest of Latin America branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 227 Rest of Latin America branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 228 Rest of Latin America branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 229 Rest of Latin America branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 230 Rest of Latin America branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 231 Middle East & Africa branded generics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 232 Middle East & Africa branded generics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 233 Middle East & Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 234 Middle East & Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 235 Middle East & Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 236 Middle East & Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 237 Middle East & Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 238 Middle East & Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 239 Middle East & Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 240 Middle East & Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 241 Saudi Arabia branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 242 Saudi Arabia branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 243 Saudi Arabia branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 244 Saudi Arabia branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 245 Saudi Arabia branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 246 Saudi Arabia branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 247 Saudi Arabia branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 248 Saudi Arabia branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 249 South Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 250 South Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 251 South Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 252 South Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 253 South Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 254 South Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 255 South Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 256 South Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 257 Rest of Middle East and Africa branded generics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 258 Rest of Middle East and Africa branded generics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 259 Rest of Middle East and Africa branded generics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 260 Rest of Middle East and Africa branded generics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 261 Rest of Middle East and Africa branded generics market size, by application, 2018 - 2022 (USD Million)
  • TABLE 262 Rest of Middle East and Africa branded generics market size, by application, 2023 - 2032 (USD Million)
  • TABLE 263 Rest of Middle East and Africa branded generics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 264 Rest of Middle East and Africa branded generics market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Branded generics industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug class
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix
  • FIG 16 Strategic dashboard, 2022